Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goldberg

Showing results (1451-1460 of 1,605) with videos related to

Pageof 161
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases AnalysisMyung-Ju Ahn, Chao-Hua Chiu, Ying Cheng, et al.
Journal of Affective Disorders|March 15, 2026
Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signalJacob D Meyer, Shania J E Kelly, John M Gidley, et al.
JMIR Mental Health|June 12, 2026
Prevalence and Predictors of Self-Reported Adverse Experiences in Digital Meditation Training: 2 Randomized Controlled TrialsPolina Beloborodova, Lillian M Smith, Kevin M Riordan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2012
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancerSarah B Goldberg, Jeffrey G Supko, Joel W Neal, et al.
Molecular Cancer|May 29, 2026
NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defectsNoelia Vilariño, Miguel López de Rodas, Maria Villalba-Esparza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD StudyHelena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
<i>De novo</i> mutations mediate phenotypic switching in an opportunistic human lung pathogenAlexandra J Poret, Matthew Schaefers, Christina Merakou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Global analysis of gene activity during Arabidopsis seed development and identification of seed-specific transcription factorsBrandon H Le, Chen Cheng, Anhthu Q Bui, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
JMIR Research Protocols|September 24, 2020
Stories to Communicate Individual Risk for Opioid Prescriptions for Back and Kidney Stone Pain: Protocol for the Life STORRIED Multicenter Randomized Clinical TrialZachary F Meisel, Erica B Goldberg, Abby R Dolan, et al.
Pageof 161

Showing results (1451-1460 of 1,605) with videos related to

Sort By:
Pageof 161
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases AnalysisMyung-Ju Ahn, Chao-Hua Chiu, Ying Cheng, et al.
Journal of Affective Disorders|March 15, 2026
Exercise priming to enhance therapeutic bond and behavioral activation in CBT for MDD: a randomized controlled target-engagement trial with remission signalJacob D Meyer, Shania J E Kelly, John M Gidley, et al.
JMIR Mental Health|June 12, 2026
Prevalence and Predictors of Self-Reported Adverse Experiences in Digital Meditation Training: 2 Randomized Controlled TrialsPolina Beloborodova, Lillian M Smith, Kevin M Riordan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2012
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancerSarah B Goldberg, Jeffrey G Supko, Joel W Neal, et al.
Molecular Cancer|May 29, 2026
NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defectsNoelia Vilariño, Miguel López de Rodas, Maria Villalba-Esparza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD StudyHelena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
<i>De novo</i> mutations mediate phenotypic switching in an opportunistic human lung pathogenAlexandra J Poret, Matthew Schaefers, Christina Merakou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Global analysis of gene activity during Arabidopsis seed development and identification of seed-specific transcription factorsBrandon H Le, Chen Cheng, Anhthu Q Bui, et al.
Cancer Treatment Reviews|August 16, 2024
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscapeMichael Weller, Jordi Remon, Stefan Rieken, et al.
JMIR Research Protocols|September 24, 2020
Stories to Communicate Individual Risk for Opioid Prescriptions for Back and Kidney Stone Pain: Protocol for the Life STORRIED Multicenter Randomized Clinical TrialZachary F Meisel, Erica B Goldberg, Abby R Dolan, et al.
Pageof 161